MyFinsight
Home
Blog
About
Contact
Maturities of short-term
investments
$15,826K
Proceeds from exercise of
options
$105K
Net cash provided by
(used in) investing...
$3,257K
Net cash provided by
financing activities
$105K
Canceled cashflow
$12,569K
Net change in cash
and cash...
-$8,926K
Canceled cashflow
$3,362K
Stock-based compensation
expense
$1,660K
Prepaid expenses and
other current assets
-$606K
Amortization of right-of-use
assets
$134K
Depreciation
$87K
Purchases of short-term
investments
$12,569K
Net cash used in
operating activities
-$12,288K
Canceled cashflow
$2,487K
Net loss
-$12,345K
Accounts payable and
accrued liabilities
-$1,847K
Other assets
$295K
Operating lease
liabilities
-$186K
Accretion of discounts on
short-term investments,...
$93K
Accounts receivable and
unbilled receivable
$9K
Back
Back
Cash Flow
Cardiff Oncology, Inc. (CRDF)
Cardiff Oncology, Inc. (CRDF)
source: myfinsight.com